Due to COVID-19, new study enrollment is being assessed on a case by case basis. If you have any questions please call our central phone number at 616-391-1230.

Print

Cancer Research Consortium of West Michigan

Myeloma Clinical Trials

Provided drugs are underlined

For more information, call the CRCWM Main office at 616.391.1230 or 800.336.5079

Narrow List by Age:

Myeloma

Daratumumab/rHuPH20+/- Lenalidomide as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Relapsed Disease, and Subsequently Progressed on Lenalidomide (Lenalidomide-Refractory Disease)

CCDR

Cancer clinical trials are research studies for developing better ways of detecting, treating, and eventually preventing cancer. By taking part in a clinical trial, you are among the first to receive new research treatments before they are widely available. Your participation in a clinical trial will influence the future direction of cancer care.

If you are interested in participating in a clinical trial, consult with your physician. Please note: clinical trials are not risk free. Patients must explore the options that are best for their individuals needs with the help of their physician.